Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dalmau

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Radiologia|October 5, 2015
Triple-negative breast carcinoma: heterogeneity in immunophenotypes and pharmacokinetic behaviorM Vilagran Fraguell, M Sentís Crivillé, J del Riego Ferrari, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 17, 2018
SEOM clinical guidelines in early stage breast cancer (2018)F Ayala de la Peña, R Andrés, J A Garcia-Sáenz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 14, 2020
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancerI Alvarez-Lopez, S Bezares, E Dalmau Portulas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 12, 2013
Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic responseP Sánchez-Rovira, M A Seguí, A Llombart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2010
Infiltrating ductal carcinoma: infiltrates at the exit site of a central venous access port deviceI Moya Horno, L A Fernández Morales, E Dalmau Portulas, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Radiologia|October 5, 2015
Triple-negative breast carcinoma: heterogeneity in immunophenotypes and pharmacokinetic behaviorM Vilagran Fraguell, M Sentís Crivillé, J del Riego Ferrari, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 17, 2018
SEOM clinical guidelines in early stage breast cancer (2018)F Ayala de la Peña, R Andrés, J A Garcia-Sáenz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 14, 2020
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancerI Alvarez-Lopez, S Bezares, E Dalmau Portulas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 12, 2013
Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic responseP Sánchez-Rovira, M A Seguí, A Llombart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2010
Infiltrating ductal carcinoma: infiltrates at the exit site of a central venous access port deviceI Moya Horno, L A Fernández Morales, E Dalmau Portulas, et al.
Pageof 2